According to Dr. Sanjay Gupta, his long-running documentary series “Weed” has grown far beyond its original scope, evolving into an ongoing examination of cannabis, medicine, and patient experience.
When filming began in 2012, the intention was to produce a single documentary exploring a controversial plant and its possible medical uses. Instead, the project became a continuing series, with each installment revisiting the topic as new evidence and personal stories emerged. The latest chapter, titled “Weed 8,” turns its attention to women and their increasing reliance on cannabis for health concerns.
Across months of reporting and travel, a consistent theme emerged. Many women are turning to cannabis after exhausting conventional options. They included older patients coping with cancer therapies, professionals dealing with menopause-related symptoms, and athletes managing chronic conditions such as endometriosis. Again and again, the accounts echoed a similar frustration—standard treatments had failed to deliver relief.
This reflects a broader issue in medicine. Women’s health concerns have long faced skepticism within the medical system. Symptoms are often minimized or misinterpreted, leaving many without clear diagnoses or effective care. Even today, women are underrepresented in clinical research, despite clear biological differences that influence how treatments work. The result is a knowledge gap that continues to affect outcomes.
Menopause highlights the gap sharply. Hormone therapy once appeared to offer answers, but safety concerns shifted public perception and limited its use. With few alternatives, increasing numbers of women are exploring cannabis. Data now suggests that women, particularly in midlife and beyond, are using it at higher rates than men.
In places like Oklahoma, this shift is especially visible. A state once known for strict drug policies has seen rapid growth in its medical marijuana industry. Within that space, women are playing a leading role. Many have built small businesses centered on cannabis products tailored to women’s needs. Their work ranges from pain management solutions to sleep aids and wellness education.
What stands out is the intent behind these efforts. For these entrepreneurs and advocates, cannabis represents more than a product. It offers a sense of control in situations where they once felt overlooked. Their approach combines personal experience with emerging science, often developed outside traditional institutions.
Research is beginning to catch up, with medical organizations calling for a reassessment of cannabis classification, citing growing evidence of its therapeutic potential. Studies are exploring its role in managing neurological disorders, chronic pain, and autoimmune conditions. Female researchers are contributing significantly to this work, helping expand understanding in areas that directly affect women.
Still, policy changes lag behind scientific progress, creating real consequences for patients seeking access.
“Weed 8” builds on that legacy by focusing on how women are navigating their health choices today. Across different communities, many are choosing to rely on their own experiences while also engaging with emerging research. They are sharing information, comparing results, and holding one another accountable.
While cannabis is not a universal solution, it represents a starting point for many women. It offers a way to manage symptoms, regain balance, and engage more actively in healthcare decisions.
What is unfolding now is both a cultural and personal shift. As attitudes toward cannabis continue to change, so too does the conversation about women’s health. “Weed 8” captures this moment, showing how progress is unfolding not only in laboratories and policy discussions but also in everyday lives, where individuals are finding new paths forward.
Medical marijuana firms like Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) could capture a bigger fraction of the market by developing more medical cannabis products that are specifically designed to address the unique health challenges that women face.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN